These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 20109138)
21. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives. Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J Front Immunol; 2018; 9():947. PubMed ID: 29770138 [TBL] [Abstract][Full Text] [Related]
22. The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells. Ramachandran M; Dimberg A; Essand M Semin Cancer Biol; 2017 Aug; 45():23-35. PubMed ID: 28257957 [TBL] [Abstract][Full Text] [Related]
23. Cancer vaccines. Any future? Myc LA; Gamian A; Myc A Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):249-59. PubMed ID: 21644030 [TBL] [Abstract][Full Text] [Related]
24. Tumor antigen-based immunotherapy and immunoprevention of cancer. Ryan SO; Gantt KR; Finn OJ Int Arch Allergy Immunol; 2007; 142(3):179-89. PubMed ID: 17106205 [TBL] [Abstract][Full Text] [Related]
25. The present status and future prospects of peptide-based cancer vaccines. Hirayama M; Nishimura Y Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694 [TBL] [Abstract][Full Text] [Related]
26. [Oncoimmunology: some fundamental problems of cancer immunotherapy]. Nedospasov SA; Kuprash DV Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902 [TBL] [Abstract][Full Text] [Related]
31. Cancer vaccines: between the idea and the reality. Finn OJ Nat Rev Immunol; 2003 Aug; 3(8):630-41. PubMed ID: 12974478 [TBL] [Abstract][Full Text] [Related]
32. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011 [TBL] [Abstract][Full Text] [Related]
33. Cancer vaccines: translation from mice to human clinical trials. Maeng H; Terabe M; Berzofsky JA Curr Opin Immunol; 2018 Apr; 51():111-122. PubMed ID: 29554495 [TBL] [Abstract][Full Text] [Related]
34. Immune based therapies in cancer. Krüger C; Greten TF; Korangy F Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098 [TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy of solid tumor: perspectives on vaccine and cell therapy]. Ikeda H; Shiku H Nihon Rinsho; 2012 Dec; 70(12):2043-50. PubMed ID: 23259373 [TBL] [Abstract][Full Text] [Related]
36. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology? Fry TJ; Lankester AC Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319 [TBL] [Abstract][Full Text] [Related]
37. [Advances in immunotherapy for pediatric cancer]. Xu X; Zhao H; Tang Y Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):231-4. PubMed ID: 24824398 [No Abstract] [Full Text] [Related]
38. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. Neeson P; Paterson Y Immunol Invest; 2006; 35(3-4):359-94. PubMed ID: 16916758 [TBL] [Abstract][Full Text] [Related]